| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Oramed Pharmaceuticals Inc. (ORMP) have been net sellers, shedding 50,000 shares worth roughly $226K on balance.
Counted by filing, the last 12 months brought no open-market purchases and 4 sales by 2 insiders worth about $1.2M. There were none in the 12 months before that either.
2 of the 4 sales in the last 12 months were made under a Rule 10b5-1 trading plan; the rest were not.
No insider has bought ORMP shares in the open market in the last two years. The last purchase on record was by Arie Mayer on April 3, 2023.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.14M | $16.85M | - | |
| Other | 1.55M | $6.31M | - | |
| COO | 1.33M | $5.41M | - | |
| CFO | 861.1K | $3.50M | - | |
| Dir | 168.0K | $683.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Joshua Hexter | COO & Cbo | Sell10b5-1 | 30,000 | $4.51 | $135,330.00 | -2.2% | - | - | |
| Oct 1, 2026 | Avraham Gabay | Chief Financial Officer | Sell10b5-1 | 20,000 | $4.51 | $90,200.00 | -2.3% | - | - | |
| Jul 1, 2026 | Joshua Hexter | COO & Cbo | Sale+OE | 137,000 | $4.46 | $611,431.00 | -11.8% | +1.7% | - | |
| Jul 1, 2026 | Avraham Gabay | Chief Financial Officer | Sell | 73,360 | $4.51 | $330,743.56 | -9.8% | +1.7% | - | |
| Apr 4, 2023 | Arie Mayer76 | Director | Buy | 8,809 | $2.22 | $19,517.98 | +48.9% | +63.9% | +27.3% | |
| Mar 16, 2023 | Nadav Kidron67 | President and CEO | Buy | 26,000 | $2.04 | $53,014.00 | +26.0% | +74.7% | +32.1% | |
| Mar 14, 2023 | Miriam Kidron | Chief Scientific Officer | Sell | 100,000 | $2.01 | $201,000.00 | -33.1% | +88.0% | +32.5% | |
| Mar 14, 2023 | Nadav Kidron67 | President and CEO | Buy | 100,000 | $2.01 | $201,000.00 | New | +88.0% | +32.5% | |
| Mar 14, 2023 | Yadin Rozov80 | Director | Buy | 70,000 | $2.02 | $141,570.00 | +424.2% | +88.0% | +32.5% | |
| Jan 3, 2023 | Michael Rabinowitz | Chief Commercial Officer | Sell | 13,325 | $12.55 | $167,195.04 | -9.6% | -82.2% | -80.9% |